Treatment > Carmustine, Radiation Related Pathology


J Neurooncol. 2005 Nov 29;1-3 [Epub ahead of print]. (Case Report)


Abstract

Response to chemotherapy of a radiation-induced glioblastoma multiforme

Nicolardi L, Deangelis LM

School of Medicine, Padua University, Padua, Italy.

Background. Radiation-induced glioblastoma multiforme (GBM) is particularly resistant to treatment and therapeutic options are limited. 
We report a patient with a radiation-induced GBM who had a complete response to carmustine and survived for 44 months. 

Patients and Methods. Case report of a 38-year-old man with a radiation-induced GBM that responded to carmustine. 

Results. Our patient developed a left occipital GBM 35 years after a left cerebellar astrocytoma was treated with surgery and radiation therapy (4500 rad). 
The GBM was treated with subtotal resection followed by four cycles of carmustine; a complete response was achieved. 
He relapsed 34 months after diagnosis and with further surgery survived 44 months from his diagnosis of GBM. 

Conclusion. GBMs may be a late complication of radiation treatment for pediatric brain tumors. 
If further radiotherapy is not a therapeutic option, chemotherapy may result in prolonged survival.


PMID: 16314941 [PubMed - as supplied by publisher]
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16314941&query_hl=10


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP